中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
14期
405-406
,共2页
杨东君%晏波%刘宏%代立武
楊東君%晏波%劉宏%代立武
양동군%안파%류굉%대립무
膝骨性关节炎%医用臭氧
膝骨性關節炎%醫用臭氧
슬골성관절염%의용취양
Knee osteoarthritis%Medical ozone
目的研究低浓度医用臭氧用于治疗膝骨性关节炎的临床效果。方法48例膝骨性关节炎患者随机分成两组,A 组为医用臭氧组,B组为注射生理盐水组。记录两组患者用药前(T0),用药后1周(T1)、1个月(T2)、3个月(T3)、6个月(T4)VAS 评分、WOMAC 关节炎指数评分。结果和治疗前比较,治疗后 A 组 VAS 评分、WOMAC 关节炎指数均显著性下降(P <0.01),而 B 组无显著性差异(P >0.05);和 B 组比较,低浓度臭氧组(A 组)治疗后各时间点 VAS 评分显著性降低(P <0.05),WOMAC 关节炎指数显著性降低(P <0.01)。结论膝关节内注射低浓度臭氧能显著降低膝骨性关节炎患者的疼痛评分,改善患者 WOMAC 关节炎指数评分,是一种安全有效地治疗方法。
目的研究低濃度醫用臭氧用于治療膝骨性關節炎的臨床效果。方法48例膝骨性關節炎患者隨機分成兩組,A 組為醫用臭氧組,B組為註射生理鹽水組。記錄兩組患者用藥前(T0),用藥後1週(T1)、1箇月(T2)、3箇月(T3)、6箇月(T4)VAS 評分、WOMAC 關節炎指數評分。結果和治療前比較,治療後 A 組 VAS 評分、WOMAC 關節炎指數均顯著性下降(P <0.01),而 B 組無顯著性差異(P >0.05);和 B 組比較,低濃度臭氧組(A 組)治療後各時間點 VAS 評分顯著性降低(P <0.05),WOMAC 關節炎指數顯著性降低(P <0.01)。結論膝關節內註射低濃度臭氧能顯著降低膝骨性關節炎患者的疼痛評分,改善患者 WOMAC 關節炎指數評分,是一種安全有效地治療方法。
목적연구저농도의용취양용우치료슬골성관절염적림상효과。방법48례슬골성관절염환자수궤분성량조,A 조위의용취양조,B조위주사생리염수조。기록량조환자용약전(T0),용약후1주(T1)、1개월(T2)、3개월(T3)、6개월(T4)VAS 평분、WOMAC 관절염지수평분。결과화치료전비교,치료후 A 조 VAS 평분、WOMAC 관절염지수균현저성하강(P <0.01),이 B 조무현저성차이(P >0.05);화 B 조비교,저농도취양조(A 조)치료후각시간점 VAS 평분현저성강저(P <0.05),WOMAC 관절염지수현저성강저(P <0.01)。결론슬관절내주사저농도취양능현저강저슬골성관절염환자적동통평분,개선환자 WOMAC 관절염지수평분,시일충안전유효지치료방법。
Objective To study the clinical effect low concentration of medical ozone for the treatment of knee osteoarthritis. Methods 48 cases of knee osteoarthritis were randomLy divided into two groups. A group is medical ozone group, B group is saline injection group. Record the two groups before treatment (T0), after administration of 1 week (T1), 1 month (T2), 3 (T3), 6 months (T4), VAS score, WOMAC arthritis index score. Results After treatment, the VAS score, the WOMAC arthritis index was significantly decreased (P <0.01) in two group. Compared with B group, the VAS and the WOMAC arthritis index score in A group after treatment at each time point significantly decreased (P <0.01). Conclusion Knee joint injection of low concentrations of ozone can significantly reduce pain scores of patients with knee osteoarthritis, Improve patients' WOMAC arthritis index scores, and is a safe and effective treatment.